DERJ DERJ Dent Res J Dent Res J Dental Research Journal 1735-3327 2008-0255 Wolters Kluwer - Medknow India DERJ-21-38 00038 10.4103/drj.drj_53_24 2 Original Article Evaluation of the effects of probiotic pills on the oral plaque indices: A randomized clinical trial Nilchian Firoozeh 1 Esrafili Mohammadreza 2 Hosseini Nafiseh 3 Department of Oral Public Health, Dental Materials Research Center, Dental Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran Student Research Committee, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran Address for correspondence: Dr. Firoozeh Nilchian, Department of Oral Public Health, Dental Materials Research Center, Dental Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. E-mail: f_nilchian@dnt.mui.ac.ir May2024 12072024 21 1 38 27012024 20022024 11032024 Copyright: © 2024 Dental Research Journal 2024 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Background:

Clinical trials investigating the efficacy of oral health prevention materials have conventionally used indices to evaluate the amount of plaque on tooth surfaces. Various methods, including the use of probiotics, have been suggested to prevent oral disease. The present study was conducted to investigate the probiotic products available in Iranian pharmacies that are used for the prevention of dental disease.

Materials and Methods:

In this double-blind randomized clinical trial, 40 students of medicine and pharmacy were randomly allocated into two equal groups of intervention and control using random allocation software. The intervention group used a probiotic pill containing Streptococcus salivarius M18 and K12 bacteria every night before going to bed. The control group used a mouth freshener tablet with the same flavor as the probiotic tablet every night before going to bed. The mean number of Streptococcus mutans bacteria in both the groups was calculated before and after using probiotic pills. The data were staticali analyzed by descriptive statistics (central tendency and dispersion) and inferential statistics (paired t-test and independent t-test) and Kolmogorov-Smironove tests (P<0.05).

Results:

The plaque index values at the beginning of the study showed no statistical differences between the intervention and control groups (P = 0.85). The plaque index values in the intervention group before and after the intervention were 0.41 and 0.75, respectively, which showed a statistically significant difference (P < 0.05). The plaque index values in the control group before and after the intervention were 0.42 and 0.42, respectively, which indicated no statistically significant difference (P > 0.05).

Conclusion:

The mean plaque index in the group using probiotic tablets was significantly increased compared to those of the control group. However, further studies are suggested to evaluate these products.

Clinical trial plaque index probiotics Streptococcus mutans Streptococcus salivarius OPEN-ACCESS TRUE
INTRODUCTION

Plaque bacteria that ferment sucrose produce acids that lower the pH level to below 5.0 in vitro and cause enamel demineralization. However, only Streptococcus mutans of all these species significantly cause caries in germ-free animals with a high-sucrose diet. This shows that microbial acid production is not the sole determinant of caries, and S. mutans must have other characteristics that are responsible for its severity and make it the main cause of caries.[1] S. mutans forms several complex glucans such as fructans, dextrans, and mutans. In vitro experiments have shown that these glucans enable S. mutans to adhere firmly to surfaces and cause tooth decay.[1] Adding fluoride to drinking water, producing different mouthwashes, and using pit and fissure sealants, topical products such as fluoride gels and varnishes, xylitol emulsifiers, and probiotics are among the procedures to prevent caries.

According to the definition of the World Health Organization, probiotics are living microorganisms that are prescribed in sufficient amounts and provide health benefits to the host.[2] Streptococcus salivarius M18 and K12 (S. S. K12, S. S. M18) are probiotic bacteria used in various food products. It has been shown that these species of S. salivarius are capable of producing bacteriocin and have a narrow range of effects on preventing the growth of some other bacteria.[3]

S. S. M18 is able to reduce the number of S. mutans but has no specific effect on the health of the gingiva and periodontal tissues.[4] This caries prevention mechanism is attributed to the ability of S. S. M18 to produce urease and dextranase enzymes. These enzymes are able to deal with the formation of dental plaque and prevent caries.[5,6] It has also been shown that S. S. K12 is effective in preventing and treating diseases such as halitosis, acute otitis media, pharyngotonsillitis, and oral candidiasis by producing bacteriocin.[7-9] A study on the effect of S. S. M18 on the risk of caries and oral health showed a reduction in the amount of S. mutans and dental plaque.[10] In another study, the comparison of saliva sample cultures at the beginning and end of the intervention showed a slight difference in the number of S. mutans between the two groups and between each group compared to the baseline. However, 9 children who had higher M18 salivary bacteria in their mouth showed a significant decrease in the number of S. mutans. Moreover, 87.5% of M18 salivary bacteria users who had a large amount of plaque at the beginning of the intervention showed a significant decrease in plaque formation, while those with a large plaque in the placebo group showed 44% decrease in plaque formation.[4] Most of the studies conducted on probiotics have shown that their oral and dental effects are highly dependent on the type of probiotic bacteria used, and few studies have been done in this field, especially on S. S. K12 and S. S. M18 probiotic bacteria. Furthermore, very few academic studies have been done on Iranian probiotic products as well as their effects on the prevention of bacterial plaque, which requires further studies of this type.

MATERIALS AND METHODS

This double-blind randomized clinical trial was conducted on 40 students of medicine and pharmacy, with the age range of 19–35 years, at Isfahan University of Medical Sciences. A checklist of subjects was prepared at the beginning and end of this study. The exclusion criteria were students with orthodontic appliances or 6-month orthodontic treatments, students who had taken antibiotics in the last month, students undergoing incomplete dental treatments, and students with immune system diseases. Further, students who needed dental treatment during the intervention, used <90% of the consumables, needed to take antibiotics during the intervention, got bacterial and viral diseases during the intervention, and changed the number of times they brushed their teeth and the type of toothpaste and mouthwash, or used a new oral hygiene method were excluded after the study. As it is shown on the diagram in figure 1, 47 volunteers enrolled for this study and 7 of them were excluded due to the study exclusion criteria. Four underwent dental treatment and 3 had orthodontic appliances. The participants’ flow diagram is represented in Figure 1.

The participants’ flow diagram.

Randomization and blinding

The subjects were randomly divided into two groups of 20 people each. To ensure the participants in both the groups were equal in number, the block randomization method was used. Blocking is usually used to balance the number of samples assigned to each of the studied groups. This feature helps the researchers to have the same number of samples assigned to each of the studied groups in cases, where intermediate analyses are needed during the sampling process. The size of all the blocks was equal, and there were 40 blocks, including 20 participants in the intervention group (probiotic consumers) and 20 participants in the control group (mouth freshener tablets) in this two-group trial.

The randomization tool used was the random allocation software (version 2.0), which is able to perform block randomization in addition to simple randomization. Allocation concealment, which is used to implement a random sequence on the participants, was also used, so that the assigned group was not known before the allocation of the individual. Sequentially numbered, sealed, opaque envelopes were used, in which each of the random sequences created was recorded on a card, and the cards were placed inside the envelopes, respectively. To maintain a random sequence, the outer surface of the envelopes was numbered in the same order. Finally, the envelopes were glued and placed in a box. At the time of the participants’ registration, based on the order in which the eligible participants were included in the study, one of the envelopes was opened and the allocated group of that participant was revealed. In this study, the double-blind method was used. For this purpose, the participants did not know whether the product they were using contained salivary probiotics or xylitol freshener, and the products were not delivered to them in the company’s original packaging. Furthermore, the statistician who analyzed the data was blinded to the participants’ information. The randomization and blinding process were done by the main author.

Products

In order to equalized the oral hygiene situation of the both groups we asked them to use similar tooth paste (Signal, Iran, LC1515/z/38). Test group received Probiotic tablet (Lactogam, Zist Takhmir Co, Iran) and control group recived xylitol freshener tablet (Iceberg, Shiva Co, Iran, lc 7009/Z/56) as placebo. It should be noted that the amount of xylitol in the mouth freshener tablets is much lower than the therapeutic and effective dose of xylitol and has no effect on the number of S. mutans. Both products have a mint flavor.

Ethical considerations

This study was registered in the Ethics Committee of Isfahan University of Medical Sciences, with the ethics code IR.MUI.RESEARCH.REC.1400.297. It also received the scientific code IRCT20210811052147N1 from the Center for Clinical Trials of Iran. All the information of the participants in this study were kept confidential, and only the main authors were aware of it. Moreover, the participants were fully aware of the research conditions. The results of the study were provided to the participants after the intervention.

Intervention

According to the instructions of the probiotic product, the intervention group sucked one probiotic tablet every night before going to bed and after brushing their teeth for 20 days. The control group sucked a mouth freshener every night after brushing their teeth before going to bed for 20 days. Further, both the groups were required not to make any new changes in their oral hygiene habits and to continue the training process before the intervention. The preintervention process means that they should not change the number of times they brush their teeth, or if they did not use mouthwash or dental floss, they would not do this during this 20-day period and should follow the instructions given. Participants were informed of all these conditions, and these health habits were determined through a checklist before and after the intervention. The oral health level before and after the study was determined by the plaque index using the common Silness–Loe method based on the WHO Oral Health Surveys, 5th ed., 2013. The students were contacted by phone once every 5 days and their cooperation was ensured. Furthermore, a text message was sent to the participants every night to remind them of taking probiotic pills and freshener tablets.

Statistical analysis

The data were collected through Excel software and analyzed by SPSS software (IBM, USA, version 24) using descriptive statistics (central tendency and dispersion) and inferential statistics (paired t-test and independent t-test). Furthermore, the normality of the data was checked using the Kolmogorov–Smirnov test. To determine the plaque index of the patients, their dental plaque thickness was evaluated by probing the mesial, distal, buccal, and palatal surfaces of all teeth using a Williams periodontal probe. The plaque index of an individual was determined by summing the values obtained for each tooth and calculating the averages. To determine the plaque index, Silness and Löe[11] reference values were taken as a basis:

Plaque index 0: No plaque is in the area adjacent to the gingiva

Plaque index 1: There is a plaque in the form of a thin film on the gingival margin

Plaque index 2: There is a visible plaque in the gingival pocket and gingival margin

Plaque index 3: There is a dense plaque in the gingival pocket and on the gingival margin.

RESULTS

According to Table 1, based on the results of the Kolmogorov–Smirnov test, the data were normally distributed (P > 0.05). For inferential analysis, parametric paired and independent t-tests were used.

Results of Kolmogorov–Smirnov test to check the normality of the data

Table 2 presents the comparison of mean scores of research variables in two periods for each group. This comparison was done using the paired t-test.

Comparison of mean and standard deviation of plaque in each group before and after the intervention and their test results

In the control group, the mean plaque score was 0.426 ± 0.259 before the intervention and 0.420 ± 0.273 after the intervention (P > 0.05). Therefore, in the control group, the number of plaques before and after the intervention did not change. In the intervention group, the mean plaque score was 0.411 ± 0.334 before the intervention and 0.759 ± 0.406 after the intervention (P < 0.05). Therefore, in the intervention group, the amount of plaque increased significantly after the intervention.

The mean plaque of the first period was compared between the control and intervention groups, indicating no significant difference between the two groups (P > 0.05). The mean plaque of the second period was compared between the control and intervention groups, which revealed a significant difference between the two groups (P < 0.05) Table 3.

Comparison of the average of plaque in the test and control groups with each other before and after the intervention

DISCUSSION

The present study is one of the first studies on probiotic products made in Iran and their effectiveness in preventing dental caries. The results showed that the dental plaque index in the intervention group that received probiotic tablets (S. salivarius bacteria M18 and K12) were significantly increased. Di Pierro et al. reported that the 90-day consumption of the probiotic S. salivarius M18 could prevent dental disease,[10] which is completely different from the results of the present study. It should be noted that the products used in the present study are made in Iran and the manufacturer of the products is different from that of the study mentioned above.

Moreover, Söderling et al. demonstrated that four types of probiotic products could effectively reduce the number of Streptococcus bacteria,[11] which is not in line with the results of the present study. Further, they reported that the in vitro antibacterial activity of probiotic products against S. mutans is highly dependent on the pH of the environment, and the increase in the plaque in the present study can be because this product may have changed the pH of the environment in favor of S. mutans.

Contrary to the results of the current study, Burton et al. found probiotic products to be effective in reducing caries.[4] In the present study, the probiotic bacteria used may make food more easily accessible to harmful bacteria in the mouth and teeth, thereby increasing their population. In a systematic review conducted by Poorni et al. in 2019, the quality of the articles on this subject was very poor, so they recommended further studies in this regard.[12]

Babina et al. indicated that the probiotic product had a positive effect on reducing microbial plaque contamination, which is again different from the results of the present study.[13] In the present study, the probiotic bacteria used may have changed the pH of the environment, thereby balancing the normal flora of the area (Echo logic Nich change) and ultimately increasing harmful oral bacteria.

CONCLUSION

The mean plaque index in the group using these Iranian probiotic tablets was significantly increased compared to the control group. Accordingly, further research is suggested to evaluate these Iranian products.

Financial support and sponsorship

This research conducted as a doctoral thesis in dentistry funded by the Isfahan University of Medical Sciences.

Conflicts of interest

The authors of this manuscript declare that they have no conflicts of interest, real or perceived, financial or non-financial in this article.

Acknowledgment

This study was carried out as a free project (research code: 1400184) and then a doctoral thesis in dentistry funded by the Isfahan University of Medical Sciences. The authors appreciate Isfahan University of Medical Sciences and Dr. Tahmine Narimani for her invaluable guidance.

REFERENCES Loesche WJ. Chapter 99 microbiology of dental decay and periodontal disease. In: Medical Microbiology. 4th ed. Galveston, TX: University of Texas Medical Branch at Galveston; 1996. FAO/WHO. Evaluation of Health and Nutritional Properties of Powder Milk and Live Lactic Acid Bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report; 2001. p. 134. Wescombe PA, Upton M, Renault P, Wirawan RE, Power D, Burton JP, Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius. Microbiology (Reading) 2011;157:12909. Burton JP, Drummond BK, Chilcott CN, Tagg JR, Thomson WM, Hale JD, Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: A randomized double-blind, placebo-controlled trial. J Med Microbiol 2013;62:87584. Chen YY, Clancy KA, Burne RA. Streptococcus salivarius urease: Genetic and biochemical characterization and expression in a dental plaque streptococcus. Infect Immun 1996;64:58592. Ohnishi Y, Kubo S, Ono Y, Nozaki M, Gonda Y, Okano H, Cloning and sequencing of the gene coding for dextranase from Streptococcus salivarius. Gene 1995;156:936. Power DA, Burton JP, Chilcott CN, Dawes PJ, Tagg JR. Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis 2008;27:12613. Tagg JR. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. Indian J Med Res 2004; 119 Suppl: 136. Venekamp RP, Burton MJ, van Dongen TM, van der Heijden GJ, van Zon A, Schilder AG. Antibiotics for otitis media with effusion in children. Cochrane Database Syst Rev 2016;2016:CD009163. Di Pierro F, Zanvit A, Nobili P, Risso P, Fornaini C. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: Results of a randomized, controlled study. Clin Cosmet Investig Dent 2015;7:10713. Söderling EM, Marttinen AM, Haukioja AL. Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro. Curr Microbiol 2011;62:61822. Poorni S, Srinivasan MR, Nivedhitha MS. Probiotic Streptococcus strains in caries prevention: A systematic review. J Conserv Dent 2019;22:1238. Babina K, Salikhova D, Polyakova M, Svitich O, Samoylikov R, Ahmad El-Abed S, The effect of oral probiotics (Streptococcus salivarius k12) on the salivary level of secretory immunoglobulin a, salivation rate, and oral biofilm: A pilot randomized clinical trial. Nutrients 2022;14:1124.

Refbacks

  • There are currently no refbacks.